Keros Therapeutics Statistics
Total Valuation
KROS has a market cap or net worth of $564.55 million. The enterprise value is -$105.27 million.
Important Dates
The last earnings date was Wednesday, August 6, 2025, after market close.
Earnings Date | Aug 6, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
KROS has 40.62 million shares outstanding. The number of shares has increased by 21.79% in one year.
Current Share Class | 40.62M |
Shares Outstanding | 40.62M |
Shares Change (YoY) | +21.79% |
Shares Change (QoQ) | -1.00% |
Owned by Insiders (%) | 1.07% |
Owned by Institutions (%) | 76.32% |
Float | 28.13M |
Valuation Ratios
The trailing PE ratio is 29.87.
PE Ratio | 29.87 |
Forward PE | n/a |
PS Ratio | 2.39 |
Forward PS | n/a |
PB Ratio | 0.80 |
P/TBV Ratio | 0.80 |
P/FCF Ratio | 10.68 |
P/OCF Ratio | 10.30 |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 21.11, with a Debt / Equity ratio of 0.03.
Current Ratio | 21.11 |
Quick Ratio | 20.40 |
Debt / Equity | 0.03 |
Debt / EBITDA | 2.51 |
Debt / FCF | 0.34 |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 3.33% and return on invested capital (ROIC) is 0.03%.
Return on Equity (ROE) | 3.33% |
Return on Assets (ROA) | 0.03% |
Return on Invested Capital (ROIC) | 0.03% |
Return on Capital Employed (ROCE) | 0.04% |
Revenue Per Employee | $1.38M |
Profits Per Employee | $111,083 |
Employee Count | 169 |
Asset Turnover | 0.38 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, KROS has paid $8.12 million in taxes.
Income Tax | 8.12M |
Effective Tax Rate | 30.20% |
Stock Price Statistics
The stock price has decreased by -69.00% in the last 52 weeks. The beta is 1.34, so KROS's price volatility has been higher than the market average.
Beta (5Y) | 1.34 |
52-Week Price Change | -69.00% |
50-Day Moving Average | 14.02 |
200-Day Moving Average | 21.38 |
Relative Strength Index (RSI) | 48.80 |
Average Volume (20 Days) | 452,781 |
Short Selling Information
The latest short interest is 4.84 million, so 11.92% of the outstanding shares have been sold short.
Short Interest | 4.84M |
Short Previous Month | 5.05M |
Short % of Shares Out | 11.92% |
Short % of Float | 17.21% |
Short Ratio (days to cover) | 10.81 |
Income Statement
In the last 12 months, KROS had revenue of $232.84 million and earned $18.77 million in profits. Earnings per share was $0.47.
Revenue | 232.84M |
Gross Profit | 219.41M |
Operating Income | 312,000 |
Pretax Income | -168.05M |
Net Income | 18.77M |
EBITDA | 1.67M |
EBIT | 312,000 |
Earnings Per Share (EPS) | $0.47 |
Full Income Statement Balance Sheet
The company has $690.22 million in cash and $17.95 million in debt, giving a net cash position of $672.26 million or $16.55 per share.
Cash & Cash Equivalents | 690.22M |
Total Debt | 17.95M |
Net Cash | 672.26M |
Net Cash Per Share | $16.55 |
Equity (Book Value) | 706.73M |
Book Value Per Share | 17.40 |
Working Capital | 698.10M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $55.04 million and capital expenditures -$1.96 million, giving a free cash flow of $53.08 million.
Operating Cash Flow | 55.04M |
Capital Expenditures | -1.96M |
Free Cash Flow | 53.08M |
FCF Per Share | $1.31 |
Full Cash Flow Statement Margins
Gross margin is 94.23%, with operating and profit margins of 0.13% and 8.06%.
Gross Margin | 94.23% |
Operating Margin | 0.13% |
Pretax Margin | 11.55% |
Profit Margin | 8.06% |
EBITDA Margin | 0.72% |
EBIT Margin | 0.13% |
FCF Margin | 22.80% |
Dividends & Yields
KROS does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -21.79% |
Shareholder Yield | -21.79% |
Earnings Yield | 3.31% |
FCF Yield | 9.36% |
Dividend Details Analyst Forecast
The average price target for KROS is $20.56, which is 47.91% higher than the current price. The consensus rating is "Buy".
Price Target | $20.56 |
Price Target Difference | 47.91% |
Analyst Consensus | Buy |
Analyst Count | 14 |
Revenue Growth Forecast (5Y) | 104.81% |
EPS Growth Forecast (5Y) | -13.85% |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | |
Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
KROS has an Altman Z-Score of 15.29 and a Piotroski F-Score of 7.
Altman Z-Score | 15.29 |
Piotroski F-Score | 7 |